Completed
In response to the CARES Act, the National Academies of Sciences, Engineering, and Medicine will establish an ad hoc committee to conduct a study to examine the security of the United States medical product supply chain. The committee will assess and evaluate the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain.